M. Decupere

Artifactual hypocalcaemia after intravenous administration of gadodiamide (Omniscan).

R. Oyen, D. Kuypers, K. Claes, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Secondary renal amyloidosis due to long-standing tubulointerstitial nephritis in a patient with Sjögren syndrome.

E. Lerut, Y. Vanrenterghem, D. Kuypers, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

A case of pseudorenal failure - spontaneous rupture of the urinary bladder.

S. Bourgeois, D. Devriendt, K. Lesage, 2017, Acta gastro-enterologica Belgica.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.